MedPath

FRAGMIN

FRAGMIN

Approved
DIN Number

02352664

Drug Class

Human

Market Date

Feb 1, 2011

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02352664
AIG Number0126861002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AB04 DALTEPARIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous ,  Subcutaneous
AHFS Classification20:12.04.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

DALTEPARIN SODIUMActive
Strength: 12500 UNIT / 0.5 ML
Monograph: DALTEPARIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.